Rapid electrochemical immunodetection of SARS-CoV-2 using a pseudo-typed vesicular stomatitis virus model

• Published in: Talanta (Oxford) Vol. 239; p. 123147
• Main Authors: Ashur, Idan, Alter, Joel, Werbner, Michal, Ogungbile, Abraham, Dessau, Moshe, Gal-Tanamy, Meital, Vernick, Sefi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.2022
• Subjects: Animals; COVID-19; Diagnostic Tests, Routine; Electrochemical impedance spectroscopy; Humans; Immunosensors; Pandemics; Rapid diagnostic testing; SARS-CoV-2; SARS-CoV-2 pseudovirus; Spike Glycoprotein, Coronavirus; Vesicular Stomatitis; COVID-19; Immunosensors; Rapid diagnostic testing; SARS-CoV-2 pseudovirus; Electrochemical impedance spectroscopy
• ISSN: 0039-9140; 1873-3573; 1873-3573
• DOI: 10.1016/j.talanta.2021.123147

The COVID-19 pandemic has highlighted the need for reliable and accurate diagnostic tools that provide quantitative results at the point of care. Real-time RT-PCR requires large laboratories, a skilled workforce, complex and costly equipment, and labor-intensive sample processing. Despite tremendous efforts, scaling up RT-PCR tests is seemingly unattainable. To date, hundreds of millions of COVID-19 tests have been performed globally, but the demand for timely, accurate testing continues to outstrip supply. Antigen-based rapid diagnostic testing is emerging as an alternative to RT-PCR. However, the performance of these tests, namely their sensitivity, is still inadequate. To overcome the limitations of currently employed diagnostic tests, new tools that are both sensitive and scalable are urgently needed. We have developed a miniaturized electrochemical biosensor based on the integration of specific monoclonal antibodies with a biochip and a measurement platform, and applied it in the detection of Spike S1 protein, the binding protein of SARS-CoV-2. Using electrochemical impedance spectroscopy, quantitative detection of sub-nanomolar concentrations of Spike S1 was demonstrated, exhibiting a broad detection range. To demonstrate the applicability of the biosensor, we have further developed a SARS-CoV-2 pseudovirus based on Spike protein-pseudo-typed VSV platform. Specific detection of different concentrations of pseudovirus particles was feasible in <30 min. This new tool may largely contribute to the fight against COVID-19 by enabling intensive testing to be performed and alleviating most of the hurdles that plague current diagnostics. [Display omitted] •An electrochemical immunosensor was developed to enable rapid detection of SARS-CoV-2.•Detection of SARS-CoV-2 Spike S1 antigen at nanomolar concentrations was demonstrated.•SARS-CoV-2 pseudovirus particles were detected in <30min.